(Q30448091)

21 June 2017

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma (English)

1 reference

Adaptive radiation therapy

21 June 2017

0 references

1 reference

1

Nader Pouratian

0 references

Jason P Sheehan

series ordinal

5

object named as

Jason P Sheehan

1 reference

21 June 2017

2

R Webster Crowley

1 reference

21 June 2017

Jonathan H Sherman

3

1 reference

PubMed ID

19330482

21 June 2017

Jay Jagannathan

series ordinal

4

1 reference

21 June 2017

29 March 2009

1 reference

Journal of Neuro-Oncology

21 June 2017

1 reference

21 June 2017

94

1 reference

21 June 2017

3

1 reference

21 June 2017

409-418

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-009-9873-9

21 June 2017

0 references

cites work

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9873-9

Assumptions in the radiotherapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9873-9

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9873-9

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9873-9

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9873-9

Isolation and characterization of human malignant glioma cells from histologically normal brain.

21 January 2018

1 reference

12 December 2020

Radiosurgery as part of the initial management of patients with malignant gliomas

1 reference

12 December 2020

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

12 December 2020

Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

1 reference

12 December 2020

Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced pe

1 reference

12 December 2020

Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery

1 reference

12 December 2020

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

12 December 2020

Salvage therapy in patients with glioblastoma: is there any benefit?

1 reference

12 December 2020

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

12 December 2020

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

12 December 2020

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

12 December 2020

Selection bias, survival, and brachytherapy for glioma

1 reference

12 December 2020

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme

1 reference

12 December 2020

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

1 reference

12 December 2020

Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?

1 reference

12 December 2020

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

1 reference

12 December 2020

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

1 reference

12 December 2020

Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence

1 reference

12 December 2020

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

1 reference

12 December 2020

Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas

1 reference

12 December 2020

Measuring bias in uncontrolled brain tumor trials--to randomize or not to randomize?

1 reference

12 December 2020

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.

1 reference

12 December 2020

Beneficial effects of the radioprotectant 21-aminosteroid U-74389G in a radiosurgery rat malignant glioma model.

1 reference

12 December 2020

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

12 December 2020

Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy

1 reference

12 December 2020

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

12 December 2020

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

1 reference

12 December 2020

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

10.1007/S11060-009-9873-9

Identifiers

DOI

1 reference

PubMed ID

19330482

Dimensions Publication ID

21 June 2017

0 references

1 reference

PubMed ID

19330482